Internal Medicine
Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis.
10 Dec, 2021 | 09:58h | UTC
Large observational study in Israel showed a third dose (booster) of the Pfizer–BioNTech vaccine had 90% effectiveness at preventing death due to Covid-19 compared to a two-dose regimen.
9 Dec, 2021 | 10:35h | UTCBNT162b2 Vaccine Booster and Mortality Due to Covid-19 – New England Journal of Medicine
Editorial: Booster Doses and Prioritizing Lives Saved
Review: Neuropsychiatric assessment and management of the ICU survivor.
10 Dec, 2021 | 10:01h | UTC
[Press release – not published yet] Lab study suggests a third dose (booster) of the Pfizer–BioNTech vaccine may be necessary to provide an adequate immune response to the Omicron variant.
9 Dec, 2021 | 10:29h | UTCPress release: Pfizer and Biontech provide update on Omicron variant
Commentaries:
Omicron likely to weaken COVID vaccine protection – Nature
Pfizer-BioNTech says COVID booster should protect against Omicron – CIDRAP
Covid: Pfizer says booster shot promising against Omicron – BBC
Large observational study in Israel showed a third dose (booster) of the Pfizer–BioNTech vaccine reduced the rates of confirmed Covid-19 and severe illness compared to a two-dose regimen.
9 Dec, 2021 | 10:32h | UTCProtection against Covid-19 by BNT162b2 Booster across Age Groups – New England Journal of Medicine
Editorial: Booster Doses and Prioritizing Lives Saved
As 57 countries report Omicron cases, Pfizer says its boosters offer protection – but WHO cautions more research is needed.
9 Dec, 2021 | 10:28h | UTCSee also: Covid: Vaccines should work against Omicron variant, WHO says – BBC
Multiple early studies find notable Omicron vaccine evasion.
9 Dec, 2021 | 10:26h | UTCMultiple early studies find notable Omicron vaccine evasion – CIDRAP
Related: A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants.
RCT: In critically ill adults undergoing tracheal intubation, use of a bougie did not significantly increase the incidence of successful first attempt intubation vs. with use of an endotracheal tube with stylet.
9 Dec, 2021 | 10:22h | UTCEffect of Use of a Bougie vs Endotracheal Tube With Stylet on Successful Intubation on the First Attempt Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial – JAMA (free for a limited period)
Related: Randomized Trial: Comparison of Intubation Techniques in Patients with Difficult Airways
M-A: Effects of immediate or early oral feeding on acute pancreatitis.
9 Dec, 2021 | 10:14h | UTC
Review: Current issues in the use of opioids for the management of postoperative pain.
9 Dec, 2021 | 10:18h | UTCCurrent Issues in the Use of Opioids for the Management of Postoperative Pain: A Review – JAMA Surgery (free for a limited period)
Systematic Review: Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer.
9 Dec, 2021 | 10:08h | UTC
Commentary on Twitter (thread – click for more)
https://twitter.com/ccaneloa/status/1464655542010494981
Update in the diagnosis and management of acute pulmonary embolism for the non-respiratory physician.
9 Dec, 2021 | 10:00h | UTC
Modern day management of a unilateral pleural effusion.
9 Dec, 2021 | 09:58h | UTCModern day management of a unilateral pleural effusion – Clinical Medicine Journal
Blood sugar targets in surgical intensive care: management and special considerations in patients with diabetes.
9 Dec, 2021 | 10:06h | UTCBlood Sugar Targets in Surgical Intensive Care – Deutsches Ärzteblatt International
Interstitial lung disease on the acute take for the non-respiratory physician.
9 Dec, 2021 | 09:57h | UTC
Review: Diagnosis and management of non-cystic fibrosis bronchiectasis.
9 Dec, 2021 | 09:53h | UTCDiagnosis and management of non-cystic fibrosis bronchiectasis – Clinical Medicine Journal
Review: Lung cancer for the non-respiratory physician.
9 Dec, 2021 | 09:54h | UTCLung cancer for the non-respiratory physician – Clinical Medicine Journal
WHO recommends against the use of convalescent plasma to treat COVID-19.
8 Dec, 2021 | 10:24h | UTCNews Release: WHO recommends against the use of convalescent plasma to treat COVID-19 – World Health Organization
See Guidance: WHO’s living guidelines on COVID-19 therapeutics
Infographic: A living WHO guideline on drugs for covid-19 – The BMJ
Commentary on Twitter (thread – click for more)
Convalescent plasma is a transfusion of blood plasma from someone who has recovered from #COVID19, and is used as a treatment for COVID19 https://t.co/Bobq7OTDGq pic.twitter.com/pfO1sFvUpJ
— World Health Organization (WHO) (@WHO) December 7, 2021
A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants.
8 Dec, 2021 | 10:22h | UTCOriginal Study: SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection – medRxiv
Commentary from the author on Twitter (thread – click for more)
We have completed our first experiments on neutralization of Omicron by Pfizer BNT162b2 vaccination elicited immunity
Manuscript available at https://t.co/rGaEB9GdmS
and should be available on medRxiv in the coming days
— Alex Sigal (@sigallab) December 7, 2021
See also (thread – click for more)
New work from AHRI's @sigallab strongly suggests that the SARS-CoV-2 #Omicron variant escapes antibody immunity induced by the Pfizer vaccine, but that considerable immunity is retained in people who were both vaccinated & previously infected. https://t.co/AZWi3qexin pic.twitter.com/3phPFyKEPh
— Africa Health Research Institute (@AHRI_News) December 7, 2021
RCT: In patients with severe Covid-19, high-flow oxygen therapy reduced the likelihood of invasive mechanical ventilation and decreased the time to clinical recovery compared to conventional oxygen therapy.
8 Dec, 2021 | 10:15h | UTCRelated:
Video | COVID-19 Update: Omicron Variant.
8 Dec, 2021 | 10:09h | UTCCOVID-19 Update: Omicron Variant – JAMA
Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors.
8 Dec, 2021 | 09:58h | UTC
ESC Position Paper: Optimal follow-up after acute pulmonary embolism.
8 Dec, 2021 | 10:02h | UTC
Commentary on Twitter
Do you routinely discuss how/when to resume sporting activities and traveling with your PE patients? Or future cardiovascular risk? Check this recent ESC/ERS position paper on optimal follow-up of acute PE for these and other key aspects of counselling: https://t.co/KEQ7FnFwXX
— Erik Klok (@Erik_Klok_MD) December 7, 2021
Review: Perioperative pain management issues unique to older adults undergoing surgery.
8 Dec, 2021 | 09:52h | UTC
Raising awareness for time-limited trial discussion upon ICU triage and admission.
8 Dec, 2021 | 09:57h | UTCRaising awareness for time-limited trial discussion upon ICU triage and admission – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Enhancing situational awareness/prompt time-limited trial discussion vs burden/harm of inappropriate #ICU admission
F functional impairment
R recurrent hospitalisations
A advanced malignancy/chronic diseases
I irreversible organ failure
L long 🏥 stayhttps://t.co/C3aR2lbZtt pic.twitter.com/IB0xjSGVup— Intensive Care Medicine (@yourICM) December 6, 2021


